Skip to main content
. 2021 Sep 17;10(2):1551–1566. doi: 10.1007/s40122-021-00319-z

Table 5.

Patient use of healthcare utilization and associated costs in the 6 months pre- and post-erenumab stratified by persistence

Pre-erenumab Post-erenumab
All (N = 4437) Erenumab persistent (N = 1853) Erenumab non-persistent (N = 2584) All (N = 4437) Erenumab persistent (N = 1853) Erenumab non-persistent (N = 2584)
Inpatient hospitalizations
 Mean (SD) 0.1 (0.3) 0.1 (0.3) 0.1 (0.3) 0.1 (0.3) 0.0 (0.2) 0.1 (0.3)
 95% CI (0.1, 0.1) (0.0, 0.1) (0.1, 0.1) (0.0, 0.1) (0.0, 0.1) (0.1, 0.1)
Length of stay, days
 Mean (SD) 5.2 (3.9) 4.6 (2.5) 5.6 (4.5) 5.2 (4.3) 4.4 (3.2) 5.5 (4.7)
 95% CI (4.7, 5.7) (4.0, 5.1) (4.9, 6.3) (4.6, 5.8) (3.7, 5.2) (4.7, 6.3)
 Mean (SD) costs $1680 ($9995) $1403 ($8316) $1879 ($11,040) $1696 ($19,939) $957 ($6515) $2227 ($25,527)
ER visits
 Mean (SD) 0.5 (2.2) 0.5 (2.9) 0.4 (1.4) 0.4 (1.4) 0.4 (1.4) 0.4 (1.4)
 95% CI (0.4, 0.5) (0.4, 0.6) (0.4, 0.5) (0.3, 0.4) (0.3, 0.4) (0.4, 0.5)
 Mean (SD) costs $657 ($3581) $636 ($4227) $673 ($3035) $533 ($2401) $500 ($2738) $557 ($2127)
Outpatient office visits
 Mean (SD) 8.5 (7.9) 8.2 (7.5) 8.7 (8.2) 8.0 (7.8) 7.7 (7.2) 8.3 (8.2)
 95% CI (8.2, 8.7) (7.9, 8.5) (8.4, 9) (7.8, 8.2) (7.3, 8.0) (8.0, 8.6)
 Mean (SD) costs $1143 ($1951) $1128 ($2381) $1154 ($1572) $1049 ($1473) $1024 ($1676) $1067 ($1308)
Brain imaginga studies
 Mean (SD) 0.2 (0.5) 0.2 (0.5) 0.2 (0.5) 0.1 (0.4) 0.1 (0.4) 0.1 (0.4)
 95% CI (0.2, 0.2) (0.1, 0.2) (0.2, 0.2) (0.1, 0.1) (0.1, 0.1) (0.1, 0.2)
 Mean (SD) costs $170 ($606) $166 ($643) $173 ($577) $110 ($503) $84 ($459) $129 ($531)
 Total associated costsb mean (SD) $3651 ($11,736) $3334 ($10,921) $3879 ($12,285) $3389 ($20,457) $2564 ($7786) $3980 ($25,969)

a(CT + MRI + Nuclear Med + Angiography)

bTotal associated costs include inpatient, ER, office visits, and brain imaging studies